PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Consuming certain sweeteners may increase risk of early puberty

2025-07-13
(Press-News.org) SAN FRANCISCO—Consuming certain sweeteners commonly found in foods and beverages may increase the risk of early puberty in children, particularly among those who are genetically predisposed, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.

The researchers found that consuming aspartame, sucralose, glycyrrhizin and added sugars was significantly associated with a higher risk of early puberty, especially in children with certain genetic traits. The more of these sweeteners the teens consumed, the higher their risk of central precocious puberty.

“This study is one of the first to connect modern dietary habits — specifically sweetener intake — with both genetic factors and early puberty development in a large, real-world cohort,” said Yang-Ching Chen, M.D., Ph.D., of Taipei Municipal Wan Fang Hospital and Taipei Medical University in Taipei, Taiwan. “It also highlights gender differences in how sweeteners affect boys and girls, adding an important layer to our understanding of individualized health risks.”

A type of early puberty known as central precocious puberty is increasingly common. It can lead to emotional distress, shorter adult height, and increased risk of future metabolic and reproductive disorders.

Chen’s previous research found that certain sweeteners can directly influence hormones and gut bacteria linked to early puberty. For example, one artificial sweetener called acesulfame potassium or AceK was shown to trigger the release of puberty-related hormones by activating “sweet taste” pathways in brain cells and increasing stress-related molecules. Another sweetener, glycyrrhizin—found in licorice—was found to change the balance of gut bacteria and reduce the activity of genes involved in triggering puberty.

“This suggests that what children eat and drink, especially products with sweeteners, may have a surprising and powerful impact on their development,” Chen said.

The new findings come from the Taiwan Pubertal Longitudinal Study (TPLS), begun in 2018. The study included data from 1,407 teens. Central precocious puberty was diagnosed in 481 teens. The researchers assessed teens’ sweetener intake through validated questionnaires and testing of urine samples. Genetic predisposition was quantified using polygenic risk scores derived from 19 genes related to central precocious puberty. Early puberty was diagnosed based on medical exams, hormone levels and scans.

Sucralose consumption was linked to a higher risk of central precocious puberty in boys and consumption of glycyrrhizin, sucralose and added sugars was associated with a higher risk of central precocious puberty in girls.

“The findings are directly relevant to families, pediatricians and public health authorities,” Chen said. “They suggest that screening for genetic risk and moderating sweetener intake could help prevent early puberty and its long-term health consequences. This could lead to new dietary guidelines or risk assessment tools for children, supporting healthier development.”


# # #

 

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions. 

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

END



ELSE PRESS RELEASES FROM THIS DATE:

Experts suggest screening women with diabetes for intent to conceive at every doctor visit

2025-07-13
SAN FRANCISCO—A joint guideline released today from the Endocrine Society and the European Society of Endocrinology (ESE) recommends women with diabetes receive proper preconception care and access to emerging diabetes technology and therapeutics to manage their blood sugar before, during and after pregnancy. Adverse pregnancy outcomes such as miscarriages or birth defects are common in individuals with pre-existing diabetes and are often related to modifiable factors such as maternal high blood sugar and body mass index (BMI). Screening women of reproductive age who have diabetes for intent to conceive at ...

Osteoporosis treatment benefits people older than 80

2025-07-12
SAN FRANCISCO—People who are older than 80 should be considered for osteoporosis treatment after a fracture to avoid further risk, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “The burden of osteoporosis is rising as the global population ages rapidly,” said Gianina Flocco, M.D., a resident at the Cleveland Clinic in Cleveland, Ohio. “Our study supports the initiation of osteoporosis treatment after a fracture ...

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

2025-07-12
SAN FRANCISCO—Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. Losing muscle (or lean mass) is a common side effect of weight loss in adults with obesity and may negatively affect metabolism and bone health. This is because muscle helps control blood sugar after meals and plays an important role in keeping bones strong, according to study lead researcher Melanie Haines, M.D., of Massachusetts ...

Thyroid treatment may improve gut health in people with hypothyroidism

2025-07-12
SAN FRANCISCO—People with an underactive thyroid may have an increased risk of developing small intestinal bacterial overgrowth (SIBO), a risk that may be reduced with thyroid hormone treatment, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “We now know that people with hypothyroidism, especially those with autoimmune thyroiditis, are more likely to develop SIBO, but this risk appear to be mitigated in those taking thyroid medications,” said Ruchi Mathur, M.D., Director of the Diabetes Outpatient ...

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

2025-07-12
SAN FRANCISCO—Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “These data are the first to show the combined use of tirzepatide and menopause hormone therapy significantly increases treatment effectiveness in postmenopausal women,” said Regina Castaneda, ...

High blood sugar may have a negative impact on men’s sexual health

2025-07-12
SAN FRANCISCO—Metabolic health factors, including small increases in blood sugar, are the main drivers of change in the reproductive systems and sexual functioning of aging men, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Although age and testosterone levels have long been considered an impetus for men’s declining sexual health, our research indicates that these changes more closely correlate with modest increases in blood sugar and other metabolic changes,” said Michael Zitzmann, ...

Emotional health of parents tied to well-being of children with growth hormone deficiency

2025-07-12
SAN FRANCISCO—Strong emotional links between children with chronic conditions and their family caregivers suggest that improving parent well-being may directly benefit a child’s overall health and coping mechanisms, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. The study observed children with growth hormone deficiency and their caregivers to better understand the impact that physical or emotional distress can have. Findings suggest that when parents or caregivers of children with growth hormone deficiency report symptoms of stress, anxiety and depression, so does the child they ...

Oxytocin may reduce mood changes in women with disrupted sleep

2025-07-12
SAN FRANCISCO—Oxytocin, often called “the love hormone,” may play a protective role in mood disturbances triggered by sleep loss and hormonal shifts during key reproductive transitions like postpartum and menopause, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. Researchers at Brigham and Women’s Hospital and Harvard Medical School studied the combined impact of sleep interruption and estrogen suppression on mood and oxytocin levels in healthy premenopausal women. Their findings suggest that oxytocin may help reduce the negative mood effects brought on by fragmented sleep, which ...

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

2025-07-12
SAN FRANCISCO—The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. "Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes,” said study author Amanda Kucinskas, ...

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

2025-07-11
https://doi.org/10.1016/j.apsb.2025.05.003 This new article publication from Acta Pharmaceutica Sinica B, discusses how a CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury.   Acute liver injury (ALI) serves as a critical precursor and major etiological factor in the progression and ultimate manifestation of various hepatic disorders. The prevention and treatment of ALI is still a serious global challenge. Given the limited therapeutic options for ALI, exploring novel targeted therapeutic agents becomes imperative. The potential therapeutic ...

LAST 30 PRESS RELEASES:

Making regular GPS ultra-precise

Webb Telescope unveils doomed star hidden in dust

UT Southwestern preventive cardiologist to receive the 2025 Chairman’s Award

Slime mold metabolites are a promising, eco-friendly repellent of root-knot nematodes

Pathological mechanism of mechanosensitive cells driving the growth of keloids

First large-scale Alzheimer disease study in brain tissue from African American donors implicates roles for many novel genes

In a nasal spray, gold “nanoparticles” deliver a targeted treatment to the brain. A potentially revolutionary approach to mental disorders and neurodegenerative diseases already has a patent

Current and recommended diets in the USA have embedded forced labor risk

AI breakthrough helps astronomers spot cosmic events with just a handful of examples

New vaccine shows promise against typhoid and invasive salmonella in first human trial

Engineered “natural killer” cells could help fight cancer

New 3D printing method ‘grows’ ultra-strong materials

Lizard genetics provide new perspective on evolution

Can a Stevia-derived sweetener improve hair loss treatment?

Method to assess the status of wild reindeer may help with conservation efforts

Do imported cut flowers spread livestock viruses?

Does prior incarceration contribute to poor health later in life?

Could slime mold microbes be a source of potent antimicrobials?

Record-breaking 2024 Amazon fires drive unprecedented carbon emissions and ecosystem degradation

Birds thrive despite pollution from ‘forever’ chemicals

Deadwood brings wild orchids to life

Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors

Medicaid expansion linked to improved long-term survival in cancer patients

Women with surgical menopause may exit workforce earlier, but hormone therapy could help

Trailblazing Young Scientists honored with $250,000 prizes at Blavatnik National Awards Gala

Revolutionary blood test for ME / Chronic Fatigue unveiled

Calorie labelling linked to 2% average reduction in energy content of menu items

Widely prescribed opioid painkiller tramadol not that effective for easing chronic pain

Exercise snacks may boost cardiorespiratory fitness of physically inactive adults

15,000 women a year with breast cancer could benefit from whole genome sequencing, say researchers

[Press-News.org] Consuming certain sweeteners may increase risk of early puberty